Odensomab 60 mg Injection
Odensomab 60 mg Injection Odensomab 60 mg is an injectable medicine containing denosumab, a monoclonal antibody used to help manage conditions involving excessive bone loss, particularly osteoporosis in people at increased risk of fractures. It works by reducing the activity of cells responsible for breaking down bone, helping preserve bone strength and improve bone mineral density. The medicine is administered as a subcutaneous injection under medical supervision.
| Brand | Odensomab |
| Storage Temperature | 2°C–8°C |
| Prescription Needed | Yes |
| Composition | Denosumab |
| Strength | 60 mg/1 mL |
| Form | Solution for Injection |
| Pack Size | 1 × 1 mL Pre-filled Syringe |
| Packaging | Pre-filled Syringe |
| Country of Origin | Made In India |
| Manufacturer | Lupin Ltd. |
Odensomab 60 mg Injection
Odensomab 60 mg Injection Odensomab 60 mg is an injectable medicine containing denosumab, a monoclonal antibody used to help manage conditions involving excessive bone loss, particularly osteoporosis in people at increased risk of fractures. It works by reducing the activity of cells responsible for breaking down bone, helping preserve bone strength and improve bone mineral density. The medicine is administered as a subcutaneous injection under medical supervision.